An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGA
Methods and Protocols · 01.06.2026 · 9 (3) · 87
DOI: 10.3390/mps9030087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Methods and Protocols, online erschienen am 01.06.2026. Verfasst von Maja Lusina Kregar und 2 weiteren Autor:innen. Beteiligte Einrichtung: HALMED, Agency for Medicinal Products and Medical Devices of Croatia, Ksaverska Cesta 4, 10000 Zagreb, Croatia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Long-acting injectables (LAIs) are widely used for chronic conditions such as schizophrenia, opioid use disorder, and HIV. Their prolonged efficacy improves adherence and reduces dosing frequency. Among these systems, poly(lactide-co-glycolide) (PLGA)-based formulations are commonly used to deliver drugs ranging from small molecules to peptides and proteins. In vitro release (IVR) tests play a critical role in evaluating drug product performance for both immediate- and prolonged-release dosage forms. However, there is a lack of standardized compendial IVR methods for the assessment of LAIs. This lack impedes the development of new drug products in this area and also complicates their regulatory approval process. Considering the complexity of drug release mechanisms and the diversity of various formulation design approaches, it is not possible to devise a universal IVR method that is applicable to all LAI products. The in vitro release test applied for quality control should be simple, robust, reproducible, and discriminatory. On the other hand, more complex biorelevant media and methods are often used during development to better reflect physiological conditions. This article provides a comprehensive review of compendial and non-compendial methods used for in vitro release testing of PLGA-based LAIs (microspheres and in situ forming implants), with the goal of aiding the development and standardization of future methodologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- HALMED, Agency for Medicinal Products and Medical Devices of Croatia, Ksaverska Cesta 4, 10000 Zagreb, Croatia.
- Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
- Research and Development, PLIVA Croatia Ltd., Teva, Prilaz Baruna Filipovića 25, 10000 Zagreb, Croatia.
- Faculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia.
ORCID-Profile: Maja Lusina Kregar, Iva Krtalić, Ivana Šagud
Zitieren
APA
Lusina Kregar, M., Krtalić, I., & Šagud, I. (2026). An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGA. Methods and Protocols, 9(3), 87. https://doi.org/10.3390/mps9030087
Vancouver
Lusina Kregar M, Krtalić I, Šagud I. An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGA. Methods and Protocols. 2026;9(3):87. doi:10.3390/mps9030087
BibTeX
@article{LusinaKregar2026,
author = {Lusina Kregar, Maja and Krtalić, Iva and Šagud, Ivana},
title = {An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGA},
journal = {Methods and Protocols},
year = {2026},
volume = {9},
number = {3},
pages = {87},
doi = {10.3390/mps9030087}
}
EUVIMED